Tuberculosis patient expenditure on drugs and tests in subsidised, public services in China: A descriptive study

Tropical Medicine and International Health

Volumn 15, Issue 1, 2010, Pages 26-32

  Liu, Qin ^a   Smith, Helen ^b   Wang, Yang ^a   Tang, Shenglan ^b   Wang, Qingliang ^a   Garner, Paul ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

China; Costes; Medicamentos hepatoprotectores; Tratamiento; Tuberculosis

Indexed keywords

ANTIINFLAMMATORY AGENT; HERBACEOUS AGENT; IMMUNOSTIMULATING AGENT; LIVER PROTECTIVE AGENT; TUBERCULOSTATIC AGENT;

DISEASE TREATMENT; HEALTH SERVICES; HOUSEHOLD INCOME; PUBLIC SERVICE; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHINA; FEMALE; FINANCIAL MANAGEMENT; GOVERNMENT; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PERSONNEL; HEALTH SERVICE; HOUSEHOLD; HUMAN; INCOME; INFANT; INTERVIEW; LIVER INJURY; LIVER PROTECTION; MAJOR CLINICAL STUDY; MALE; NEGLIGENCE; POVERTY; PRESCHOOL CHILD; PRESCRIPTION; QUESTIONNAIRE; SCHOOL CHILD; STANDARD; TREATMENT DURATION; TUBERCULOSIS; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; ATTITUDE OF HEALTH PERSONNEL; CHILD; CHILD, PRESCHOOL; CHINA; COST OF ILLNESS; DIAGNOSTIC TESTS, ROUTINE; DRUG COSTS; DRUG PRESCRIPTIONS; DRUG-INDUCED LIVER INJURY; FINANCING, GOVERNMENT; HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HUMANS; INFANT; INFANT, NEWBORN; MALPRACTICE; MIDDLE AGED; PUBLIC HEALTH; SOCIOECONOMIC FACTORS; STATE MEDICINE; TUBERCULOSIS; YOUNG ADULT;

CHINA;

EID: 72349085250     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2009.02427.x     Document Type: Article

References (18)

1. Chen ZQ, Yan W, Sun TY, Chen YL Guo HT (2005) An elementary analysis of the relationship between the doctors and the patients and countermeasures. Chinese General Practice 8, 333 335.
2. Hu DY, Liu XY, Chen J et al. (2008) Direct observation and adherence to tuberculosis treatment in Chongqing, China: a descriptive study. Health Policy and Planning 23, 43 55.
3. Liu X, Thomson R, Gong Y et al. (2007) How affordable are tuberculosis diagnosis and treatment in rural China? An analysis from community and tuberculosis patient perspectives. Tropical Medicine & International Health 12, 1464 1471.
4. Liu Q, Garner P, Wang Y, Huang BH Smith H (2008) Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health 8, 365.
5. Meng QY, Li RZ, Cheng G Blas E (2004) Provision and financial burden of TB services in a financially decentralised system: a case study from Shandong, China. The International Journal of Health Planning and Management 19, S45 S62.
6. Munro S, Lewin S, Smith H, Engel M, Fretheim A Volmink J (2007) Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Medicine 4, e238 (doi :).
7. National Bureau of Statistics of China (2008) Statistical Communiqué of the People's Republic of China on the 2007 National Economic and Social Development. NBSC, Peking.
8. Ritchie J Lewis J (eds 2003) Qualitative Research Practice: A Guide for Social Science Students and Researchers. Sage, London.
9. Smith HJ, Chen J Liu X (2008) Language and rigour in qualitative research: problems and principles in analyzing data collected in Mandarin. BMC Medical Research Methodology 8, 44.
10. Song H, Song LT, Huang T Chen WM (2003) Multidimensional reflections on the current situation of the physician-patient relationship. Chinese Journal of Hospital Administration 19, 517 519.
11. Technical director group for nationwide TB epidemiological survey in 2000 (2002) Report on the nationwide TB epidemiological survey in 2000[J]. The Journal of the Chinese Antituberculosis Association 24, 65 108.
12. Wang L, Liu J Chin D (2007) Progress in tuberculosis control and the evolving public-health system in China. Lancet 369, 691 695.
13. World Health Organization (2003) Treatment of Tuberculosis: Guidelines for National Programmes. WHO, Geneva WHO/CDS/TB 2003.313).
14. World Health Organization (2006) Guideline for the Programmatic Management of Drug-resistant Tuberculosis. WHO, Geneva WHO/HTM/TB 2006.361).
15. World Health Organization Division of Traditional Medicine (2000) General Guidelines for Methodologies on Research and Evaluation of Traditional Medicines. WHO, Geneva WHO/EDM/TRM/2000.1).
16. Xu B, Dong Hj, Zhao Q Bogg L (2006) DOTS in China - removing barriers or moving barriers? Health Policy and Planning 21, 365 372.
17. Zhan SK, Wang LX, Yin AT Blas E (2004) Revenue-driven TB control - three cases in China. The International Journal of Health Planning and Management 19, S63 S78.
18. Zhang T, Tang SL, Jun G Whitehead M (2007) Persistent problems of access to appropriate, affordable TB services in rural China: experiences of different socio-economic groups. BMC Public Health 7, 19.